Tumoral TP53 and/or CDKN2A Alterations are Not Reliable Prognostic Biomarkers in Patients with Localized Ewing Sarcoma: A Report from the Children’s Oncology Group

BACKGROUND: A growing collection of retrospective studies have suggested that TP53 mutations and/or CDKN2A deletions have prognostic significance in Ewing sarcoma. We sought to evaluate these variables in patients with localized disease treated prospectively on a single Children’s Oncology Group pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Lerman, Daniel M., Monument, Michael J., McIlvaine, Elizabeth, Liu, Xiao-qiong, Huang, Dali, Monovich, Laura, Beeler, Natalie, Gorlick, Richard G., Marina, Neyssa M., Womer, Richard B., Bridge, Julia A., Krailo, Mark D., Randall, R. Lor, Lessnick, Stephen L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376595/
https://ncbi.nlm.nih.gov/pubmed/25464386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25340
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados